Small-bowel mucosal injuries in low-dose aspirin users with obscure gastrointestinal bleeding

Table 1 Details of the characteristics of ulcerative lesions in chronic non-steroidal anti-inflammatory drug users

Age	Gender	UD	Species (duration)	Symptom	Hemoglobin (g/dL)	Location	Number	Treatment	Clinical course
67	F	Headache	Loxoprofen (6M)	Tarry stool/anemia	9.5	Ileum	Multiple	Withdrawal of NSAID	Improved
83	M	OD	Diclofenac (6M)	FOBT (+) anemia	11.5	Jejunu Ileum	Multiple	Withdrawal of NSAID	Improved
59	M	ID	LDA + clopidogrel (6M)	Tarry stool/anemia	10.3	Ileum	Multiple	Continuation of LDA PG	Improved
70	M	CD	LDA + clopidogrel (2Y)	Tarry stool/anemia	9.3	Jejunum Ileum	Multiple	Continuation of LDA PG	Improved
79	F	RA	Diclofenac (4Y)	Tarry stool/anemia	8.3	Ileum	Multiple	Continuation of NSAID rebamipide	Improved
74	F	ID	LDA + clopidogrel (1Y)	Anemia/abdominal pain	9.3	Ileum	Multiple	Continuation of LDA PG	Improved
63	M	OD	Loxoprofen (6Y)	Tarry stool/anemia	11.2	Ileum	Multiple	Withdrawal of NSAID	Improved
73	F	OD	Diclofenac (5Y)	Tarry stool/anemia	10.4	Ileum	Multiple	Withdrawal of NSAID	Improved
					10.0 ± 1.0

UD: Underlying diseases; OD: Orthopedic diseases; ID: Ischemic heart diseases; CD: Cerebrovascular diseases; RA: Rheumatoid arthritis; LDA: Low-dose aspirin; NSAID: Non-steroidal anti-inflammatory drug.